Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Humira News
Top stories
Coherus BioSciences Sells Yusimry Humira Biosimilar to King-Friend Industrial for $40M
Authors
5
7 days
Hong Kong
Economics
Bio
Articles
Latest stories
Coherus Sells Humira Biosimilar Yusimry for $40M; CHMP Issues Negative Opinions on PTC and Apellis Drugs
Authors
8
6 days
Europe
Economics
Bio
Coherus BioSciences Sells Yusimry Humira Biosimilar to King-Friend Industrial for $40M
Authors
5
7 days
Hong Kong
Economics
Bio
Keytruda Leads Top 20 Drugs Sales in 2023, Cancer, Autoimmune Diseases, COVID-19 Top Indications
Authors
4
1 month
AI
Bio
Tech
CVS Health's Switch to Hyrimoz Boosts Biosimilar Prescriptions for AbbVie's Humira; FDA Supports MRD-Negativity Endpoint in Cancer, JAMA Study Shows Clinical Benefits
Authors
7
3 months
Bio
Crime
Science
CVS Health Switch to Hyrimoz Biosimilar Captures 36% Market Share
Authors
7
3 months
Bio
Science
Boehringer Ingelheim, Sanofi Announce Layoffs Amid Market Challenges and Pipeline Reprioritization
Authors
6
3 months
Bio
Science
Boehringer Announces Thursday Layoffs Over Humira Biosimilar Sales Slump
Authors
5
3 months
Bio
Science
Previous
Next
